SILVER SPRING, MD. – A Food and Drug Administration advisory committee voted unanimously to support the approval of the antibacterial drug dalbavancin for the treatment of acute bacterial skin and...
Rheumatoid arthritis patients taking an anti–tumor necrosis factor agent who had a prior hospitalization because of an infection significantly reduced their risk of a subsequent infection-related...
Rheumatoid arthritis patients taking an anti–tumor necrosis factor agent who had a prior hospitalization because of an infection significantly reduced their risk of a subsequent infection-related...
DENVER – Of all the procedures and behaviors that place dermatologists at risk for occupational exposure, needlestick injuries rank at the top.
According to 1999 data from the National Institute...
Protocol-based resuscitation did not reduce sepsis deaths or morbidity, compared with usual care, in the Protocolized Care for Early Septic Shock study conducted at 31 U.S. academic hospitals.
Among...
Patients with HCV-HIV coinfections had significantly higher rates of hepatic decompensation vs. HCV-monoinfected patients, even when they received antiretroviral therapy and maintained low HIV RNA...
When used to treat ventilator-associated pneumonia, the antibacterial drug doripenem is linked to a greater risk of mortality and lower clinical cure rates compared with imipenem and cilastatin for...
Federal officials are proposing new targets for reducing health care–associated infections, including a 75% reduction in invasive methicillin-resistant Staphylococcus aureus infections by...
Since the West Nile virus was first detected in New York in 1999, hospitalized patients in the United States have cost an estimated $778.1 million in health care expenditures and lost productivity,...
Exam-room posters declaring a clinician’s commitment to make appropriate antibiotics prescriptions may be a simple, low-cost approach to reducing inappropriate use of antibiotics for acute...